These results suggest that Akt related signaling pathway is tightly linked to the cPA-PDE3B-cAMP pathway and thus indicate for the first time that cPA may serve as a useful molecule in targeted therapy for colon cancer. The gene discussed is AKT1; the disease is colonic neoplasm.